These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 7709167

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Total homocysteine levels relation with chronic complications of diabetes, body composition, and other cardiovascular risk factors in a population of patients with diabetes mellitus type 2.
    de Luis DA, Fernandez N, Arranz ML, Aller R, Izaola O, Romero E.
    J Diabetes Complications; 2005; 19(1):42-6. PubMed ID: 15642489
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Heterogeneous nature of microalbuminuria in NIDDM: studies of endothelial function and renal structure.
    Fioretto P, Stehouwer CD, Mauer M, Chiesura-Corona M, Brocco E, Carraro A, Bortoloso E, van Hinsbergh VW, Crepaldi G, Nosadini R.
    Diabetologia; 1998 Feb; 41(2):233-6. PubMed ID: 9498659
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Relation of homocysteine to early nephropathy in patients with Type 2 diabetes.
    Li J, Shi M, Zhang H, Yan L, Xie M, Zhuang L, Zhu Y, Chen J.
    Clin Nephrol; 2012 Apr; 77(4):305-10. PubMed ID: 22445474
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Increased plasma thrombin-activatable fibrinolysis inhibitor levels in normotensive type 2 diabetic patients with microalbuminuria.
    Yano Y, Kitagawa N, Gabazza EC, Morioka K, Urakawa H, Tanaka T, Katsuki A, Araki-Sasaki R, Hori Y, Nakatani K, Taguchi O, Sumida Y, Adachi Y.
    J Clin Endocrinol Metab; 2003 Feb; 88(2):736-41. PubMed ID: 12574207
    [Abstract] [Full Text] [Related]

  • 32. Association between homocysteine status and the risk of nephropathy in type 2 diabetes mellitus.
    Mao S, Xiang W, Huang S, Zhang A.
    Clin Chim Acta; 2014 Apr 20; 431():206-10. PubMed ID: 24534450
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Plasma Homocysteine is Associated with Retinopathy in Type 1 Diabetic Patients in the Absence of Nephropathy.
    Bulum T, Blaslov K, Duvnjak L.
    Semin Ophthalmol; 2016 Apr 20; 31(3):198-202. PubMed ID: 24785685
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Fibrinogen is a marker for nephropathy and peripheral vascular disease in type 1 diabetes: studies of plasma fibrinogen and fibrinogen gene polymorphism in the DCCT/EDIC cohort.
    Klein RL, Hunter SJ, Jenkins AJ, Zheng D, Semler AJ, Clore J, Garvey WT, DCCT/ECIC STUDY GROUP.
    Diabetes Care; 2003 May 20; 26(5):1439-48. PubMed ID: 12716802
    [Abstract] [Full Text] [Related]

  • 37. [Value of plasma growth differentiation factor-15 in diagnosis and evaluation of type 2 diabetic nephropathy].
    Li H, Gao F, Xue Y, Qian Y.
    Nan Fang Yi Ke Da Xue Xue Bao; 2014 Mar 20; 34(3):387-90. PubMed ID: 24670455
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.